MTOR and diffuse large B-cell lymphoma: To directly test our hypothesis, we treated Ly1 and DHL6 DLBCL cells with LY294002, CCI-779, and U0126 to specifically inhibit PI3K/AKT, mTOR, and ERK signals, respectively.